Stockreport

OptimizeRx Q4 2025 Earnings Preview [Seeking Alpha]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF The consensus EPS Estimate is $0.22 (-26.7% Y/Y) and the consensus Revenue Estimate is $30.91M (-4.3% Y/Y). Over the last 2 years, OPRX has beaten EPS estimates 88% o [Read more]